Death marks second fatality in growing outbreak, following the death of an unvaccinated school-aged child in Texas ...

The makers of 2 popular weight-loss drugs — Wegovy and Zepbound — are cutting prices to make the medications more affordable for people without insurance. Novo Nordisk, the Danish company behind ...

(HealthDay News) — The US Food and Drug Administration has approved TNKase (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment of acute ischemic stroke in adults.

More frequent placement of central venous catheter seen for patients with heart failure with reduced ejection fraction ...

Patients with SLE vs individuals without autoimmune disease demonstrated higher rates of peripartum complications.

On February 7, the NIH announced that it would begin capping indirect cost payments for new and existing research grants at 15%.

One-hour glucose was strongest predictor of dysglycemia on regression analyses, followed by 2-hour glucose. (HealthDay News) — Higher 1-hour blood glucose on an oral glucose tolerance test (OGTT) at 3 ...

(HealthDay News) — There appears to be a connection between prenatal per- and polyfluoroalkyl substance (PFAS) serum concentrations and some childhood cancers, according to a study published online in ...

Hybrid closed-loop insulin delivery does not affect rate of severe hypoglycemia and increases rate of ketoacidosis ...

SGLT2 inhibitors were associated with better cardioprotective effects among older adults than younger adults with type 2 diabetes.

The Food and Drug Administration (FDA) has expanded the approval of Furoscix® (furosemide injection) to include the treatment of edema in patients with chronic kidney disease (CKD), including ...

Mitomycin C gel instillation is a nonsurgical, kidney-sparing primary treatment option for patients with low-grade upper tract urothelial carcinoma (UTUC).